8-K: ImmuCell Refinances Debt, Lowers Rates & Extends Term

ImmuCell Corporation successfully refinanced its existing bank debt, securing a new loan with Maine Community Bank at a lower interest rate and extended maturity, eliminating significant near-term balloon payments.

Summary

• ImmuCell Corporation entered into a new Loan Agreement and Promissory Note with Maine Community Bank (MCB) on August 7, 2025.
• The new loan is for a principal amount of $2,327,119 at a fixed interest rate of 6.5% per annum.
• Proceeds from the new loan were used to pay off an existing MCB loan with an outstanding balance of $1,525,852 (at 7% interest) and a Finance Authority of Maine (FAME) loan with an outstanding balance of $768,209 (at 8% interest).
• The previous loans had aggregate balloon principal payments of approximately $1,946,000 due during the third quarter of 2026.
• The new loan has a five-year amortization schedule with monthly principal and interest payments beginning September 7, 2025, and matures on August 7, 2030.
• The loan is secured by a security interest in substantially all of the Company's assets.
• A nonrefundable origination fee of 0.25% of the final loan amount was payable at closing.
• The Company must maintain a minimum Pre-distribution Debt Service Coverage Ratio of 1.35:1.00, tested annually beginning December 31, 2025.

Sentiment

Score: 8

Explanation: The refinancing significantly improves the company's debt structure by lowering interest rates, extending maturity, and eliminating near-term balloon payments, which is a strong positive for financial stability and operational flexibility.

Positives

• Secured a lower fixed interest rate of 6.5% on the new loan, compared to 7% and 8% on the previous loans.
• Extended the maturity of the debt to August 7, 2030, providing longer-term financial stability.
• Eliminated significant balloon principal payments of approximately $1,946,000 that were due in Q3 2026, reducing near-term liquidity pressure.
• Maintained a productive relationship with Maine Community Bank and expressed appreciation for FAME's past support.

Negatives

• The new loan is secured by a security interest with respect to substantially all of the Company's assets.
• A prepayment premium applies if the Term Loan is refinanced with another institution prior to maturity, ranging from 5% in the first year to 1% in the fifth year of the term.
• A late fee of 6% of the regularly scheduled payment is imposed if a payment is ten or more days late.
• In the event of default, the interest rate increases by 5% per annum on the outstanding balance.

Risks

• Failure to make timely payments of principal and interest or otherwise comply with the terms of the agreements with Maine Community Bank could lead to acceleration of debt maturity and demand for full repayment.
• Non-compliance with the minimum Pre-distribution Debt Service Coverage Ratio of 1.35:1.00 could trigger an Event of Default.
• Any Material Adverse Change in the Company's financial condition or prospects could constitute an Event of Default.
• The occurrence of certain ERISA Events could result in a lien on Company assets or a Material Adverse Change.
• Fraud, material misrepresentation, or material omission by the Company or its officers in connection with the loan application or financial reporting could lead to default.

Future Outlook

The Company plans to host a conference call on August 15, 2025, to discuss unaudited financial results for the quarter ended June 30, 2025, and will make an updated Corporate Presentation slide deck available on August 14, 2025. The refinancing provides a more stable debt structure with an extended maturity, supporting future operations and strategic initiatives.

Management Comments

• "This represents a continuance of our very productive relationship with MCB."
• "We also appreciate the support from FAME for providing the smaller loan to us directly and also providing 50% loan insurance on the MCB loan when we needed it most during mid-2023."
• "By paying off the FAME loan early, the funds can now be used by others in the State of Maine."

Industry Context

ImmuCell Corporation operates in the animal health industry, specifically focusing on products for dairy and beef cattle. This debt refinancing is a company-specific financial event aimed at optimizing its capital structure and reducing financial risk, which is a common practice for companies seeking to improve their financial flexibility and long-term stability within any industry.

Comparison to Industry Standards

• NA

Related Party Transactions

• The refinancing is with Maine Community Bank, an existing lender, indicating a continued relationship.

Stakeholder Impact

• Shareholders benefit from improved financial stability due to lower interest costs and extended debt maturity, reducing immediate financial pressures.
• The company's ability to invest in its operations and strategic growth is enhanced by a more favorable debt structure.

Next Steps

• Monthly principal and interest payments on the new loan will commence on September 7, 2025.
• The Company will host a conference call on August 15, 2025, to discuss Q2 2025 financial results.
• An updated Corporate Presentation slide deck will be available on August 14, 2025.
• Annual testing of the Pre-distribution Debt Service Coverage Ratio covenant will begin with the year ending December 31, 2025.

Key Dates

Recommendation

The debt refinancing significantly strengthens ImmuCell's financial position by reducing interest expenses, extending debt maturity, and eliminating substantial near-term balloon payments. This improved capital structure enhances financial stability and provides greater flexibility for future operations and growth initiatives. While the loan is secured by company assets and includes standard covenants, the overall impact is highly positive, making the stock more attractive for investment.

Keywords

Debt Refinancing, Loan Agreement, Promissory Note, ImmuCell Corporation, ICCC, Maine Community Bank, Financial Health, Corporate Finance, SEC Filing, Animal Health